Bioequivalence of Combination Products: Special Testing Challenges
Bioequivalence testing for combination products-like dual-drug pills, topical creams, and inhalers-is far more complex than for single drugs. Regulatory hurdles, inconsistent methods, and high costs are delaying affordable generics. Here's how science and regulation are trying to catch up.
read more